Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.59 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.58 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.49 |
| ▸ | GNPAT | O15228 | 1/20 | 0.46 |
| ▸ | GSR | P00390 | 1/20 | 0.46 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.45 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.44 |
| ▸ | CPB2 | Q96IY4 | 7/20 | 0.44 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.43 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2494432 | 1.00 | SLC6A5 (0.59) | SLC6A5FOLH1NOD1GNPATGSR | |
| SCHEMBL19385942 | 1.00 | SLC6A5 (0.59) | SLC6A5FOLH1NOD1GNPATGSR | |
| SCHEMBL3455673 | 0.95 | SLC6A5 (0.54) | SLC6A5FOLH1NOD1GNPATSLC15A2 | |
| SCHEMBL4184576 | 0.95 | SLC6A5 (0.54) | SLC6A5FOLH1NOD1GNPATSLC15A2 | |
| SCHEMBL4184574 | 0.95 | SLC6A5 (0.54) | SLC6A5FOLH1NOD1GNPATSLC15A2 | |
| SCHEMBL13660230 | 0.94 | SLC6A5 (0.54) | SLC6A5FOLH1NOD1GNPATSLC15A2 | |
| SCHEMBL30645373 | 0.89 | SLC6A5 (0.56) | SLC6A5FOLH1NOD1GNPATGSR | |
| SCHEMBL29775550 | 0.87 | SLC6A5 (0.46) | SLC6A5FOLH1NOD1GNPATCA2 | |
| SCHEMBL343100 | 0.86 | SLC6A5 (0.68) | SLC6A5FOLH1NOD1GNPAT | |
| SCHEMBL5060759 | 0.86 | SLC6A5 (0.68) | SLC6A5FOLH1NOD1GNPAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 99 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250339370-A1 | PERFORMANCE-ENHANCING EXCIPIENTS AND METHODS OF REDUCING VISCOSITY AND INCREASING STABILITY OF BIOLOGIC FORMULATIONS | AVANTOR PERFORMANCE MATERIALS, LLC (US) | 2025-11-06 | — | — | US | claimed |
| EP-4319795-A1 | PERFORMANCE-ENHANCING EXCIPIENTS AND METHODS OF REDUCING VISCOSITY AND INCREASING STABILITY OF BIOLOGIC FORMULATIONS | Avantor Performance Materials, LLC (US) | 2024-02-14 | — | — | EP | claimed |
| CN-117355321-A | Performance enhancing excipients and methods for reducing viscosity and improving stability of biological agents | 安万托特性材料股份有限公司 | 2024-01-05 | — | — | CN | claimed |
| WO-2022217021-A1 | PERFORMANCE-ENHANCING EXCIPIENTS AND METHODS OF REDUCING VISCOSITY AND INCREASING STABILITY OF BIOLOGIC FORMULATIONS | AVANTOR PERFORMANCE MATERIALS, LLC (US) | 2022-10-13 | — | — | WO | claimed |
| CN-113785058-A | Methods of making and using amber-specific phage display libraries | 得克萨斯A&M大学系统 | 2021-12-10 | — | — | CN | claimed |
| US-20180298065-A1 | PROTEASE-RESISTANT STREPTAVIDIN | EUROPEAN MOLECULAR BIOLOGY LABORATORY (DE) | 2018-10-18 | — | — | US | claimed |
| EP-3353290-A1 | PROTEASE-RESISTANT STREPTAVIDIN | European Molecular Biology Laboratory (DE) | 2018-08-01 | — | — | EP | claimed |
| CN-108291214-A | The Streptavidin of antiprotease | 欧洲分子生物学实验室 | 2018-07-17 | — | — | CN | claimed |
| CN-105277712-B | A kind of method for identifying the modification of lysine ε amino side chains monomethylation | 杭州景杰生物科技有限公司 | 2017-07-11 | — | — | CN | claimed |
| WO-2017050947-A1 | PROTEASE-RESISTANT STREPTAVIDIN | EUROPEAN MOLECULAR BIOLOGY LABORATORY (DE) | 2017-03-30 | — | — | WO | claimed |
| US-20090186853-A1 | COMPOSITIONS COMPRISING N-PROPANOYL DERIVATIVES OF AMINO ACIDS, AMINOCARBOHYDRATES AND DERIVATIVES THEREOF | YU RUEY J | 2009-07-23 | — | — | US | claimed |
| US-20080241862-A1 | PROPIONYL AND BUTYRYL LYSINE MODIFICATIONS IN PROTEINS | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM | 2008-10-02 | — | — | US | claimed |
| EP-1865953-A4 | COMPOSITION COMPRISING N-PROPANOYL DERIVATIVES OF AMINO ACIDS, AMINOCARBOHYDRATES AND DERIVATIVES THEREOF | YU RUEY J (US) | 2008-04-30 | — | — | EP | claimed |
| EP-1865953-A2 | COMPOSITION COMPRISING N-PROPANOYL DERIVATIVES OF AMINO ACIDS, AMINOCARBOHYDRATES AND DERIVATIVES THEREOF | Yu, Ruey J., Dr. (US) | 2007-12-19 | — | — | EP | claimed |
| WO-2006101940-A2 | COMPOSITION COMPRISING N-PROPANOYL DERIVATIVES OF AMINO ACIDS, AMINOCARBOHYDRATES AND DERIVATIVES THEREOF | YU, RUEY, J. (US) | 2006-09-28 | — | — | WO | claimed |
| US-20060211754-A1 | Compositions comprising N-propanoyl derivatives of amino acids, aminocarbohydrates and derivatives thereof | YU RUEY J | 2006-09-21 | — | — | US | claimed |
| US-20050171194-A1 | Enlargement of mucocutaneous or cutaneous organs and sites with topical compositions | YU RUEY J (US) | 2005-08-04 | — | — | US | claimed |
| WO-2005055947-A2 | ENLARGEMENT OF MUCOCUTANEOUS OR CUTANEOUS ORGANS AND SITES WITH TOPICAL COMPOSITIONS | YU RUEY J (US) | 2005-06-23 | — | — | WO | claimed |
| US-20250388638-A1 | COMPOSITIONS AND METHODS FOR ORAL DELIVERY | IMAGINE PHARMA LLC (US) | 2025-12-25 | — | — | US | disclosed |
| EP-0144434-A1 | AMINO ACID-CONTAINING FAT EMULSION | AMERICAN HOSPITAL SUPPLY CORPORATION (US) | 1985-06-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388638-A1 | COMPOSITIONS AND METHODS FOR ORAL DELIVERY | VIP, FABP2, IGFBP1 | SLC6A5 2383/4885FOLH1 288/4885NOD1 2429/4885 |
| US-20250339370-A1 | PERFORMANCE-ENHANCING EXCIPIENTS AND METHODS OF REDUCING VISCOSITY AND INCREASING STABILITY OF BIOLOGIC FORMULATIONS | AADAT, KYNU, PNISR | SLC6A5 3122/4885FOLH1 923/4885NOD1 3917/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.